China Pharma (NYSE:CPHI) Earns Hold Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI) in a research report sent to investors on Saturday. The firm issued a hold rating on the stock.

China Pharma Stock Up 3.1 %

NYSE:CPHI opened at $0.24 on Friday. The firm has a fifty day simple moving average of $0.22 and a two-hundred day simple moving average of $0.22. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.26 and a current ratio of 0.79. China Pharma has a 12 month low of $0.13 and a 12 month high of $0.44.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.